CC Earnings & Financial Statements
The Chemours Company
$12.85
-$0.35(-2.65%)
39
Overall
60
Value
18
Tech
39
Quality
Market Cap
$1.99B
Volume
2.18M
52W Range
$10.44 - $28.67
Target Price
$18.10
CC earnings and financial statements: The Chemours Company's income statement, balance sheet and cash flow statement, annual and quarterly.
CC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $5.81B | $5.78B | $6.08B | $6.79B | $6.34B |
| Cost of revenue | $4.91B | $4.64B | $4.77B | $5.18B | $4.96B |
| Operating income | -$5.00M | $435.00M | -$92.00M | $788.00M | $688.00M |
| EBITDA | $343.00M | $673.00M | $206.00M | $1.20B | $1.18B |
| Net income | -$386.00M | $69.00M | -$238.00M | $578.00M | $608.00M |
| EPS (diluted) | $-2.57 | $0.57 | $-1.60 | $3.65 | $3.60 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $7.38B | $7.51B | $8.25B | $7.64B | $7.55B |
| Total liabilities | $7.13B | $6.94B | $7.51B | $6.53B | $6.47B |
| Shareholders’ equity | $250.00M | $571.00M | $737.00M | $1.11B | $1.08B |
| Cash and equivalents | $670.00M | $713.00M | $1.20B | $1.10B | $1.45B |
| Long-term debt | $4.29B | $4.26B | $4.19B | $3.79B | $3.90B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $264.00M | -$633.00M | $556.00M | $755.00M | $814.00M |
| Capital expenditure | -$206.00M | -$357.00M | -$370.00M | -$307.00M | -$277.00M |
| Free cash flow | $51.00M | -$993.00M | $186.00M | $448.00M | $537.00M |
| Dividends paid | $78.00M | $148.00M | $149.00M | - | $164.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CC | $12.85 | -2.7% | 2.18M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |